Jacob Thaysen

Chief Executive Officer at ILLUMINA

Board

Since September 25, 2023

Age

48 years

Education

Holds an M.Sc. and Ph.D. in Physics from the Technical University of Denmark.

Tenure

Joined ILMN on September 25, 2023, serving as Chief Executive Officer and member of the Board of Directors.

Also at ILLUMINA

Carissa Rollins

Chief Information Officer (CIO)

Kevin Pegels

Chief of Global Operations

Patricia Leckman

Chief People Officer

About

Born in 1975 and currently 48, the executive has built a robust foundation in the life sciences with extensive education, earning both a Master of Science and a Ph.D. in Physics from the Technical University of Denmark.

Beginning a career over 20 years ago, they have held pivotal roles including founder and Chief Technology Officer at a research and development company, positions at a Danish cancer diagnostics firm, and senior leadership roles at Agilent Technologies where significant operational improvements were achieved.

Joining ILMN on September 25, 2023, in the role of Chief Executive Officer and as a Board member, the executive now leads efforts in advancing genomics and DNA sequencing technologies to improve human health.

$ILMN Performance Under Jacob Thaysen

Past Roles

Organization	Role	Date Range	Details
Agilent Technologies	SVP, President of Life Sciences & Applied Markets Group	2018–2023	N/A
Agilent Technologies	SVP, President of Diagnostics & Genomics Group	2014–2018	N/A
Agilent Technologies	VP, General Manager, Diagnostics & Genomics	2013–2014	N/A
Dako	Corporate Vice President, R&D	2010–2013	N/A

External Roles

Organization	Role	Date Range	Details
ALDA (Analytical, Life Science & Diagnostics Association)	Chair	Since 2023	N/A

Fixed Compensation

Data from FY 2023

Component Name	Amount	Payment Schedule	Additional Details
Base Salary	$1,000,000	Annual	Annual salary for 2023.
Cash Make-Whole	$500,000	Conditional payout	Subject to clawback if resigns or terminated for cause within 2 years.
Equity Make-Whole	$3,500,000	Structured/Conditional	Composed of 70% PSUs and 30% RSUs.
ILMN Stock Matching	Up to $1,000,000 in RSUs	Based on purchase timing	Matches open-market ILMN shares purchased within 12 months; cliff-vests on the 3rd anniversary, subject to continued employment and share holding.
RSUs 2023 Grant	7,531 shares, $1,050,047 in value	Grant Date: October 5, 2023	RSU grant details for 2023.
All Other Compensation	$46,630	Other	Includes various other compensations not specified in detail.

Performance Compensation

Data from FY 2023

Performance Stock Units (PSUs) Details

Metric (Unit/Scale)	Value	Additional Details
Grant Date	October 5, 2023	Date of PSU award.
Grant Date Fair Value	$2,844,553	Total fair value of the PSU grant.
Performance Metric	Relative Total Shareholder Return (rTSR)	Measured against select companies in the Nasdaq Biotechnology Index.
Performance Period	3 years, ending December 28, 2025	PSU performance period duration.
Threshold	8,786 shares	Minimum performance level required for any payout.
Target	17,572 shares	Base performance target to achieve full award.
Maximum	30,751 shares	Cap on the payout set at 175% of the target.
Vesting Schedule	Vests at end of performance period	Vesting based on attainment of rTSR goals and continued employment.
Additional Conditions	Incentives aligned with stockholder interests	Payout ranges from 0% to 175% based on rTSR performance.